Important Note
Les produits et thérapies ne sont pas tous disponibles ou approuvés au Canada. Veuillez consulter votre professionnel de la santé Canadien.
Note:
*In adult patients (including obese patients).
† Current needles sizes: 12.7mm and 8mm.
Références
- Schwartz S, et al. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther. 2004;26(10):1663-1678.
- Kreugel G, et al. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes [published online ahead of print April 10, 2011]. Diabetes Technol Ther. 2011;13(7):737-741. doi:10.1089/dia.2011.0010.
- Hirsch LJ, et al. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin. 2010;26(6)1531-1541.
- Gibney MA, et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
- Data on file.